Pretreatment Of Plasma For Spray Drying And Storage
US-2024091667-A1 · Mar 21, 2024 · US
US9603989B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9603989-B2 |
| Application number | US-86197410-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 24, 2010 |
| Priority date | Aug 24, 2010 |
| Publication date | Mar 28, 2017 |
| Grant date | Mar 28, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods are provided for anticoagulating blood. Whole blood is drawn from a donor into a system at a draw flow rate. Anticoagulant from an anticoagulant source is pumped into the system at an anticoagulant flow rate to mix with the blood. The anticoagulated blood may be subsequently processed in any of a number of known ways, including separating it and removing at least a portion of one of the components of the blood. Thereafter, at least a portion of the remaining blood may be returned to the donor. The anticoagulant flow rate is independent of the draw flow rate and can be based on a number of factors, including the weight of the donor and the rate at which the donor can metabolize the anticoagulant.
Opening claim text (preview).
The invention claimed is: 1. A method for anticoagulating blood, comprising: drawing whole blood from a donor at a draw flow rate; adding anticoagulant containing a citrate to the whole blood at an anticoagulant flow rate; processing at least a portion of the anticoagulated blood; and returning at least a portion of the anticoagulated blood to the donor, wherein the anticoagulant flow rate is independent of the draw flow rate and is calculated using the formula “AC=S*CIR*weight/concentration”, where “AC” is the anticoagulant flow rate, “S” is a factor equal to the inverse of the percentage of anticoagulant to be returned to the donor, “CIR” is a citrate infusion rate at which the donor can metabolize said citrate, “weight” is the weight of the donor, and “concentration” is the citrate concentration of the anticoagulant. 2. The method of claim 1 , wherein the anticoagulant flow rate is substantially constant. 3. The method of claim 1 , further comprising subjecting the whole blood drawn from the donor to a pathogen inactivation procedure. 4. The method of claim 1 , wherein said adding anticoagulant to the whole blood includes continuously adding anticoagulant to the whole blood. 5. The method of claim 1 , further comprising monitoring the ratio of the draw flow rate to the anticoagulant flow rate to prevent the ratio from exceeding a preselected value.
Blood transfusion apparatus (blood infusion by syringes A61M5/14) · CPC title
Measuring or controlling the flow rate · CPC title
Extra-corporeal blood circuits (single-needle circuits A61M1/30) · CPC title
Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging · CPC title
with memories providing a history of measured variating parameters of apparatus or patient · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.